MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Tissue Regenix appoints CFO

StockMarketWire.com

Medical devices company Tissue Regenix has appointed David Cocke as CFO and director to the board with immediate effect.

Mr Cocke has over 29 years of experience in the medical device industry holding senior finance and operations positions.

In 1997, he founded NuPak Medical, an ISO-certified contract manufacturer of sterile disposable medical devices, with the company turning cash flow positive in two years and growing the production volume from 50,000 to 3 million over time.

Mr Cocke was also chief financial officer at Aperion Biologics from 2008-2017. Prior to this, he was senior director for finance and operations at Kinetic Concepts from 1993-1996.

Daniel Lee, chief executive officer, said:  'David is a well-respected finance professional in the medical device industry. His experience of implementing financial systems and management as well as operations, will be invaluable to the Group as we undertake the next stages of our capacity expansion programme.'

At 8:24am: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 0.41p


Story provided by StockMarketWire.com